Compounds > epirubicin
Page last updated: 2024-08-23

epirubicin and Endometrioma

epirubicin has been researched along with Endometrioma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, L; Han, X; Lang, J; Leng, J; Xiang, Y1
Ciavattini, A; Cignitti, M; Fabris, N; Garzetti, GG; Romanini, C1
Ciavattini, A; Cignitti, M; De Nictolis, M; Garzetti, GG; Goteri, G; Romanini, C; Tranquilli, AL1
Aitokallio-Tallberg, A; Viinikka, L; Ylikorkala, O1

Other Studies

4 other study(ies) available for epirubicin and Endometrioma

ArticleYear
Vaginal adenosarcoma arising from refractory endometriosis: a case report.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2010, Volume: 50, Issue:6

    Topics: Adenofibroma; Adenosarcoma; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Endometriosis; Epirubicin; Etoposide; Female; Gestrinone; Humans; Hysterectomy; Ifosfamide; Membrane Proteins; Ovariectomy; Salpingectomy; Treatment Outcome; Vaginal Neoplasms; Vincristine

2010
Natural killer cell activity and progression-free survival in ovarian cancer.
    Gynecologic and obstetric investigation, 1993, Volume: 35, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystadenoma; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Endometriosis; Epirubicin; Female; Follow-Up Studies; Humans; Killer Cells, Natural; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis

1993
Endometrioid carcinoma of the ovary. Retrospective study.
    European journal of gynaecological oncology, 1993, Volume: 14, Issue:1

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Endometriosis; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Retrospective Studies; Survival Rate; Tamoxifen

1993
Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.
    British journal of cancer, 1989, Volume: 60, Issue:5

    Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Endometriosis; Epirubicin; Female; Humans; Middle Aged; Ovarian Neoplasms; Thromboxane B2

1989